Target intelligence / Profile preview

Epidermal stem cell renewal (EpiSC)

Target
EpiSC
Molecular classification
Other
01

Overview

Epidermal stem cell renewal is the process by which undifferentiated stem cells located in the basal layer of the epidermis or in the hair follicle bulge undergo self-renewal divisions and produce progenitor cells that differentiate into mature keratinocytes, thereby ensuring the maintenance and repair of the skin barrier[1][2][3][4]. These stem cells are characterized by slow-cycling, high proliferative potential, and expression of specific markers such as β1 integrin, α6 integrin (CD49f), and keratins CK15/CK19. The renewal dynamics are tightly regulated: differentiation of a stem cell leads to compensatory division of neighboring cells, balancing homeostasis[1]. Aberrations in these processes are implicated in wound healing deficiencies and skin cancers[2][4]. This entry is marked "is_incorrect: true" because "Epidermal stem cell renewal" refers to a process or phenomenon, not a specific protein, receptor, or druggable target. For structured molecular targeting, focus should be on specific markers, signaling receptors (like Lgr6), or structural proteins (such as integrins) expressed by epidermal stem cells[2][3].

Other names
Epidermal progenitor cellBasal keratinocyte stem cell
02

Biological functions

Self-renewalCell proliferationDifferentiationWound healingTissue homeostasis
03

Disease associations

Cancer (especially skin cancers via dysregulation)Poor wound healing (impaired renewal)Other (aging-related skin degeneration)
04

Safety considerations

Oncogenic transformation risk if renewal is dysregulatedScarring or inadequate regeneration if stem cell pool is depleted or malfunctioning
05

Biomarkers

β1 integrin (high expression in EpiSCs)α6 integrin (CD49f) (high in basal stem cells)CD71 (low in EpiSCs)Keratins: Keratin 15 (CK15)Keratin 19 (CK19)Lgr6 (epidermal stem cell marker, especially in wound healing)

Beyond the preview

Go deeper on Epidermal stem cell renewal (EpiSC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epidermal stem cell renewal (EpiSC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call